Jacoby GM Pharma GmbH - search results

auro pharma inc - ganciclovir (ganciclovir sodium) - powder for solution - 500mg - ganciclovir (ganciclovir sodium) 500mg - nucleosides and nucleotides

Canada - English - Health Canada

mylan-leflunomide tablet

mylan pharmaceuticals ulc - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

Canada - English - Health Canada

mylan-leflunomide tablet

mylan pharmaceuticals ulc - leflunomide - tablet - 20mg - leflunomide 20mg - disease-modifying antirheumatic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

betaferon

bayer new zealand limited - interferon beta-1b 0.25mg (20% excess in quantity filled) - injection with diluent - 8 miu - active: interferon beta-1b 0.25mg (20% excess in quantity filled) excipient: albumin hydrochloric acid mannitol sodium hydroxide hydrochloric acid sodium chloride water for injection - betaferon is indicated for: · the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded, · the treatment of ambulatory patients, with relapsing-remitting multiple sclerosis characterised by at least two attacks of neurological dysfunction over a two year period followed by complete or incomplete recovery. · the reduction of frequency and severity of clinical relapses and for slowing the progression of disease in patients with secondary progressive multiple sclerosis